2002
DOI: 10.1016/s1051-0443(07)61532-2
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Pelvic Arteriovenous Malformations with Ethylene Vinyl Alcohol Copolymer (Onyx)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
35
0
3

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(39 citation statements)
references
References 10 publications
1
35
0
3
Order By: Relevance
“…However, few studies have examined its use in other organs [8,9]. It was used for treatment of large intracranial aneurysms [5]; few cases of extracranial vascular lesions were treated with Onyx including treatment of type II endoleaks during EVAR (to embolize vessels that were feeding the aneurysm), for renal and celiac-mesenteric arterial aneurysms after the placing of protective balloons [7,8], pelvic arteriovenous fi stulas [3][4][5][6][7][8][9][10][11][12], and portal vascular anomalies [10].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, few studies have examined its use in other organs [8,9]. It was used for treatment of large intracranial aneurysms [5]; few cases of extracranial vascular lesions were treated with Onyx including treatment of type II endoleaks during EVAR (to embolize vessels that were feeding the aneurysm), for renal and celiac-mesenteric arterial aneurysms after the placing of protective balloons [7,8], pelvic arteriovenous fi stulas [3][4][5][6][7][8][9][10][11][12], and portal vascular anomalies [10].…”
Section: Discussionmentioning
confidence: 99%
“…The Food and Drug Administration (FDA) approved Onyx in 2005 for the treatment of arteriovenous malformations (AVMs). It is classifi ed as a liquid, non-adhesive, non-absorbable, permanent embolic agent that can be used off -label for small and large vessels [1][2][3].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Glubran 2 acrylic glue (GEM, Viareggio, Italy) has been used in the treatment of cerebral vascular anomalies in an experimental study without major complications [10], and we have had experience using this embolic agent in patients with post-traumatic priapism [9]. We therefore chose Glubran 2 as the embolic agent.…”
Section: Discussionmentioning
confidence: 99%
“…The copolymer precipitates when coming in contact with blood due to rapid dissipation of DMSO [7]. Onyx has shown great potential in treatment of brain and spinal arteriovenous malformations as well as peripheral arteriovenous malformations [8][9][10]. It has also found increasing use in peripheral interventions such as bleeding due to iatrogenic vessel injury/pseudoaneurysm, aneurysm, malignancy/inflammation, trauma, etc.…”
Section: Discussionmentioning
confidence: 99%